Individual Response Trajectories in IBD Defines Patent Clusters for Precision Medicine
Time: 11:00 am
day: Day One
Details:
- Large level of individual heterogeneity in patients with IBD including therapy responses
- Response dynamics cluster patients into new subpopulations
- Difference in clinical therapy response are underlaid by biomarker profiles
